» Articles » PMID: 38633082

Optical Coherence Tomography for Multicellular Tumor Spheroid Category Recognition and Drug Screening Classification Via Multi-spatial-superficial-parameter and Machine Learning

Abstract

Optical coherence tomography (OCT) is an ideal imaging technique for noninvasive and longitudinal monitoring of multicellular tumor spheroids (MCTS). However, the internal structure features within MCTS from OCT images are still not fully utilized. In this study, we developed cross-statistical, cross-screening, and composite-hyperparameter feature processing methods in conjunction with 12 machine learning models to assess changes within the MCTS internal structure. Our results indicated that the effective features combined with supervised learning models successfully classify OVCAR-8 MCTS culturing with 5,000 and 50,000 cell numbers, MCTS with pancreatic tumor cells (Panc02-H7) culturing with the ratio of 0%, 33%, 50%, and 67% of fibroblasts, and OVCAR-4 MCTS treated by 2-methoxyestradiol, AZD1208, and R-ketorolac with concentrations of 1, 10, and 25 µM. This approach holds promise for obtaining multi-dimensional physiological and functional evaluations for using OCT and MCTS in anticancer studies.

Citing Articles

Automatic renal carcinoma biopsy guidance using forward-viewing endoscopic optical coherence tomography and deep learning.

Wang C, Cui H, Zhang Q, Calle P, Yan Y, Yan F Commun Eng. 2024; 3(1):107.

PMID: 39095532 PMC: 11297278. DOI: 10.1038/s44172-024-00254-9.


Optical coherence tomography for multicellular tumor spheroid category recognition and drug screening classification via multi-spatial-superficial-parameter and machine learning.

Yan F, Mutembei B, Valerio T, Gunay G, Ha J, Zhang Q Biomed Opt Express. 2024; 15(4):2014-2047.

PMID: 38633082 PMC: 11019711. DOI: 10.1364/BOE.514079.

References
1.
Lu H, Stenzel M . Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles. Small. 2018; 14(13):e1702858. DOI: 10.1002/smll.201702858. View

2.
Grimes D, Kelly C, Bloch K, Partridge M . A method for estimating the oxygen consumption rate in multicellular tumour spheroids. J R Soc Interface. 2014; 11(92):20131124. PMC: 3899881. DOI: 10.1098/rsif.2013.1124. View

3.
Keeton E, McEachern K, Dillman K, Palakurthi S, Cao Y, Grondine M . AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia. Blood. 2013; 123(6):905-13. PMC: 3916880. DOI: 10.1182/blood-2013-04-495366. View

4.
Cortes J, Tamura K, DeAngelo D, de Bono J, Lorente D, Minden M . Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers. Br J Cancer. 2018; 118(11):1425-1433. PMC: 5988656. DOI: 10.1038/s41416-018-0082-1. View

5.
Tchoryk A, Taresco V, Argent R, Ashford M, Gellert P, Stolnik S . Penetration and Uptake of Nanoparticles in 3D Tumor Spheroids. Bioconjug Chem. 2019; 30(5):1371-1384. DOI: 10.1021/acs.bioconjchem.9b00136. View